RGL4
Basic information
Region (hg38): 22:23688136-23699176
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 4 | 0 |
Variants in RGL4
This is a list of pathogenic ClinVar variants found in the RGL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-23692166-T-C | not specified | Likely benign (Apr 22, 2022) | ||
22-23692206-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
22-23692208-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
22-23692403-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
22-23692414-C-T | not specified | Likely benign (Dec 20, 2023) | ||
22-23692491-G-C | not specified | Uncertain significance (Mar 28, 2024) | ||
22-23692695-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
22-23692782-G-C | not specified | Uncertain significance (Apr 25, 2022) | ||
22-23692828-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
22-23692855-T-C | not specified | Uncertain significance (Apr 04, 2023) | ||
22-23692882-C-T | not specified | Uncertain significance (May 09, 2023) | ||
22-23692990-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
22-23693775-T-C | not specified | Uncertain significance (Mar 11, 2024) | ||
22-23693813-G-C | not specified | Likely benign (Apr 22, 2022) | ||
22-23693831-G-A | not specified | Uncertain significance (Aug 10, 2021) | ||
22-23693907-T-C | not specified | Uncertain significance (Nov 06, 2023) | ||
22-23693931-G-A | not specified | Uncertain significance (May 17, 2023) | ||
22-23693970-C-T | not specified | Uncertain significance (Jun 28, 2023) | ||
22-23694349-G-C | not specified | Uncertain significance (Nov 13, 2023) | ||
22-23694432-C-T | not specified | Uncertain significance (Jun 02, 2024) | ||
22-23694960-A-G | not specified | Uncertain significance (Oct 06, 2023) | ||
22-23694963-G-C | not specified | Uncertain significance (Apr 22, 2022) | ||
22-23694982-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
22-23694985-A-C | not specified | Uncertain significance (Feb 22, 2023) | ||
22-23694991-C-T | not specified | Uncertain significance (Apr 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RGL4 | protein_coding | protein_coding | ENST00000290691 | 11 | 11041 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.14e-13 | 0.0662 | 125516 | 2 | 230 | 125748 | 0.000923 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.276 | 285 | 272 | 1.05 | 0.0000152 | 3049 |
Missense in Polyphen | 58 | 50.665 | 1.1448 | 683 | ||
Synonymous | -0.676 | 124 | 115 | 1.08 | 0.00000681 | 983 |
Loss of Function | 0.436 | 20 | 22.2 | 0.900 | 0.00000103 | 254 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000812 | 0.000812 |
Ashkenazi Jewish | 0.00774 | 0.00767 |
East Asian | 0.000870 | 0.000870 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000644 | 0.000642 |
Middle Eastern | 0.000870 | 0.000870 |
South Asian | 0.000883 | 0.000850 |
Other | 0.00196 | 0.00196 |
dbNSFP
Source:
- Pathway
- GPCRs, Class A Rhodopsin-like
(Consensus)
Recessive Scores
- pRec
- 0.0571
Intolerance Scores
- loftool
- 0.948
- rvis_EVS
- 2.56
- rvis_percentile_EVS
- 98.74
Haploinsufficiency Scores
- pHI
- 0.0202
- hipred
- N
- hipred_score
- 0.252
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.417
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- small GTPase mediated signal transduction
- Cellular component
- cytoplasmic vesicle
- Molecular function
- guanyl-nucleotide exchange factor activity